International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Oncol Rep 51: [Related article:] 70, 2024; DOI: 10.3892/or.2024.8729
Subsequently to the publication of the above paper, the authors have drawn to the attention of the Editorial Office that they made an error in assembling the western blot data in Fig. 3C on p. 6; namely, that the western blot data correctly selected for the P53 protein with the SW620 cell line (right-hand gels) had inadvertently also been included for the γ-H2A.X protein blots with the HCT116 cell line (left-hand gels). Upon analysing this figure further in the Editorial Office, we notified the authors of possibly overlapping α-tubulin control blots for the SW62 cell line in the same figure part, and the authors realized that one of these blots had similarly been chosen incorrectly.
The revised version of Fig. 3, now showing the correct γ-H2A.X data for the HCT116 cell line and the correct α-tubulin protein blots for the SW620 cell line, is shown on the next page. The authors wish to emphasize that the corrections made to this figure do not affect the overall conclusions reported in the paper, and they are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this corrigendum. All the authors agree with the publication of this corrigendum, and also apologize to the readership for any inconvenience caused.